drugset / Trial / NCT02658409
A Multicenter, Double-blind, Parallel, Non-inferiority, Phase III Study
RandomizedParallel-groupTriple-blindPrevention
Summary
A Multicenter, Randomized, Double-blind, Active-controlled, Parallel, Non-inferiority, Phase III Study.
Timeline
- Start
- 2015-11
- Primary completion
- 2015-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluarix™tetra Syringe Inj. | Vaccine | 0.5 ml | Intramuscular |
| Subject | GC3106 | Vaccine | 0.5 ml | Intramuscular |